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I. Introduction of Hypothesis and Possible Values of the Finding 
It has been estimated that approximately 9% of people 
with cancer metastatic to bone develop a hypercalcemia 
sometime during the course of their disease. (1) This is 
seemingly rather easily explained on the basis of extensive 
osteolysis with mobilization of sufficient quantities of 
calcium to exceed the kidneys' excretory capacity. 
Some malignancies, however, haire been associated with a 
hypercalcemia without any evidence of bony metastasis. Further-
more the hypercalcemia increases with tumor size and decreases 
with surgical and chemotherapeutic extirpation of the tumor 
or soft tissue metastasis, and again increases with recurrence. 
Associated with the hypercalcemia there is often a hypercal-
curia hypophasphatemia, and decreased tubular reabso~ption of 
phospha°t;e. These findings have been .found most frequently in 
tumors of the lung, kidney, and breast as tolell as lymphomas 
and leukemia. Other tumors that have been associated with 
hypercalcemia include the stomach, cervix, bladder, uterus, 
tonSils, cartilage, and neuroblastomas. (1) 
The above blood chemistry findings suggestive of hyper-
parathyroidism led Albright and Reifersteln, in 1948, (2) 
to propose that some tmnors produced parathormone, or a para-
thormone like substance. Since that time there have been 
numerous reports of similar cases of hypercalcemia, hyper cal-
curia and hypophosphatemia without bony metastasis and normal 
(1) 
normal parathyroid glands. (3,4,5,6,7 & 8 & 14) In these 
patients other causes of hypercalcemia such as Vitamin D 
intoxication, prolonged irr~obilization, milk alkali syndrome, 
Boecks Sarcoid, and primary bone disease were adequately 
ruled out. Stone and Waterhouse, in 1961, (9) presented a 
similar case in which they found hyperplastic parathyroid 
glands and postulated that the trunor produced a trophic 
f! substance Xu. This patient 1'\TaS also cured of her hypercal-
cemia by a subtotal parathyroidectomy. However this appears 
to be an isolated case and no similar ones can be found in 
the literature. 
If some neoplasms do actually produce parathormone, the 
clinical importance of this finding is vast. Serum calcium 
levels may become an important screening test for malignan-
cies as well as other more discrete methods of evaluating 
parathyroid activity. Also, since the apparent hrunoral 
activity parallels the truaor activity, these tests can be a 
good measure of the therapeutic effectiveness of antitttmor 
drugs and surgery, and a measure of rec·urrence alerting the 
phYSician to the need of further and/or more drastic measures. 
Furthermore the hypercalcemia in itself is often a terminal 
factor in cancer deaths and an understanding of the nature of 
one of the causes of h~rpercalcemia can lead to more effective 
treatment of this problem. (10) 
(2) 
,-
II. Typical Case and Other Reports from the Literature 
It is germane to the thesis at this time to present a 
rather t~~ical case which illustrates findings consistent 
with a parathorraone secreting tumor: (~_) 
A forty-eight year old woman was ad.mitted 
on June 27, 1950, because of L~O pound weight loss, 
anorexia and vomiting of four months' duration. 
On examination the striking findings were -the 
cachexia and a soft, non..,tender multilobular mass 
arising in the left adnexal region and extending 
halfway up to the urn.bilicus. She was anemic. The 
erythrocyte sedimentation rate was 117 mm. in one 
hour. The urine concentrated to 1.023 and was 
negative for albwnin, sugar and Bence-Jones pro-
tein. The urea nitrogen was 16 mg. per cent. 
The serum calcium re.nged between 15.7 and 17.9 
mg. per cent, with serum phosphorus of 2.1 to 
3.1 mg. per cent. The serum albumin was 3.6 gm. 
per cent and globulin 2.8 gm. per cent. X-ray 
of' the chest was normal. Gastrintestinal X-ray 
study, barium enema and protoscopy were normal. 
Skeletal survey showed min1mel deminerali.zation 
with no changes suggestive of hyperparathyroidism 
or metastatic malignancy. The lamina dura of the 
teeth wa.s intact. The electrocardiograrn was 
normal except for a Q-T interval of 0.28 at a 
rate of' 110. 
It was thought that the patient had hyper-
paI'athyroidism and an ovarian neoplasm. Because 
of the irr~ediate dangers of' hypercalcemia it was 
decided to do an exploration of' the neck first. 
This was done under pentothal, nitrous OXide, 
ether and cyclopropane. Shortly af'ter induction 
and before insertion of the intratracheal tube, 
her he2.rt stopped. The chest was opened and the 
hee.rt was found in diastole. It was massaged B.nd 
spontaneous contractions began. It was thought 
safe to continue the operation and exploration of' 
the neck proceeded uneventfully. Two parathyroid 
glands on the left and one on the right were 
identified and appeared grossly normal. A small 
0.5 em. node was removed in the hope that this 
nd.ght be an adenoma but on section this proved 
to be a normal lymph node. Because of the pre-
vious cardiac arrest the sternum was not split. 
She made an uneventf'ul recovery from these 
(3 ) 
procedures, but there was no change in her 
serum calcium which continued to range between 
14.1 and 17.9 mg. per cent. It was felt that a 
reasonable effort had been made to exclude a 
parathyroid adenoma and that one should proceed 
against the ovarian neoplasm. 
At laparotomy a large multicystic tmnor was 
found arising from the pelvis and extending up 
to the l...uubilicus. No gross metastases i,,1ere noted. 
A bilateral salpingo-oophorectomy and total 
hysterectomy were done. All of the right ovary 
could not be removed from the pelvis. The histo-
pathologic diagnosis Trias papillary adenocarcinoma 
of the ovary. Careful search did not reveal 
parathyroid tissue, teratoma or unusual calcifica-
tion. Tv~or tissue was also found in the left 
ovary. The uterus showed no evidence of an 
estrogen effect. Postoperatively the patient 
did well. Three days postoperatively her serum 
calcium was 11.2 mg. per cent. Six days post-
operatively it was 10.3 mg. per cent and the 
serum phosphorus was 3.1 mg. per cent. The ser-
D~ alkaline phosphatase showed a transient rise 
to 7.1 Bodansky units (B.U.). Twelve days 
later radiotherapy was initiated to a total 
turnor dose of LI.300r. The patient gained sixteen 
pounds and her serum calcium remained at 10.5 
mg. per cent with phosphorus of 3.4 mg. per cent. 
Five months after the operation she lost a few 
pounds in weight (serum calciu..rn 11.6, phosphorus 
2.3 mg. per cent, sedimentation rate 110). Six 
months after the operatlon a mass became palpable 
in the lower right quadrant, and the serum cal-
cium rose to 13.4, then 15.5 mg. per cent, the 
phosphorus to 3.~- mg. per cent, then 4.0 mg. per 
cent with spinal fluid calciuM 5.4 and phosphorus 
1.4 mg. per cent. After temporary improvement 
she began to fail and dependent edema and severe 
abdominal pain developed. The serum calciura 
then was 16.1 mg. per cent. At the patientls 
request, she was transferred to a hospital nearer 
her home. Skeletal X-ray studies there in July, 
1951, failed to reveal bony metastases. She 
died suddenly one week later. Permission for 
autopsy could not be obtained. 
Plimpton 8.nd Gellhorn (4.) have a series of ten patients 
with malignant disease and normal bones. They all exhibited 
(4) 
symptomotology characteristic of hypercalcemia and blood 
chemistry consistent wdi.th hyperparathyroidism. Other 
causes of hyperc8.lcemia were ruled out _ Removal of the 
primary turnor in 3 of the patients was associated 'ltli th 
prompt return to normal of the serum calciurll and phosphorus 
and the alkaline phosphatase when elevated. The parathyroid 
glands were invariably found to be normal at the time of 
operation or autopsy_ This series susgested to them that 
some humoral substance was produced by these tumors although 
they could not rule out the production of some substance 
which binds calcium and transports it in excessive amounts 
causing a secondary h~rperpay·athyroidism. 
Nyers, in 1960, (11, 12, &, 13) presented a series of 
430 patients having hypercalcemia associated with malignant 
turnors. Of these, roentgenograms of the skeleton for meta-
stasis were negative in 56 patients and not done in another 
50. Therefore, 14% had hypercalcemia without bony metastasis. 
Included in his series were kidney, 17%; lung, 19%; cervix, 
50%; and lymphoma, 38%; without bony metastasis. One particu-
larly interesting presentation in his paper was a problem in 
differential diagnosis between primary hyperparathyroidism 
and hypercalcemia without bony metastasis: 
(5) 
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Special tests - phosphate clearance, calcium tolerance and 
response to cortisone were not appreciably different. 
This then shows how closely primary hyperparathyroidism 
can be mimicked and lends credence to the secretory theory. 
Myers (13) also noted that the rate of growth or 
functional capacity of a tumor may be reflected in serml1 
and urinary calciurn. He suggests that calcium studies 
may provide a precise "lay in which to measure changes in 
a tumor in response to treatm.ent and this data may be useful 
in screening antitumor agents. 
Connor, Thomas, and Howard, in 1956, (3) presented two 
cases of hypercalcemia and malignancy without skeletal 
m.etastasis. One was a 69 year old male who preoperatively 
had increased Ca++ and decreased 1'04=. A tumor of the lung 
was resected and the Oa++ returned to normal by the L~th 
postoperative day. Four months later the Oa++ increased 
and local tumor growth vvas noted. Shortly before death the 
Oa++ decreased and at autopsy the tUlllOr was found to be 
{~ 
completely necrotic. The parathyroid glands and bones were 
normal. 
Schatten, Ship, et aI, in 1959, (14) reported a case 
of a patient with hypercalcemia and hypophosphatemia associated 
with squamous cell carcinoma of the vulva. There was a 
direct correlation between the presence of tUiuor and the 
serum abnormalities. 
A fall of serum calcium and a rise of serum phosphorus 
followed excision of the tlrraor and a second rise in serum 
calcium t'ITith a fall of serml1 phosphorus followed its growth. 
The parathyroid glands were normal at autopsy and there were 
no osseous metastasis. 
Stone, Waterhouse, and Terry, in 1961, (9) presented the 
case of a 34 year old woman with carcinoma of the cervix and 
hypercalcemia without bony metastasis. A subtotal parathy-
roidectomy was done which revealed a pathologic picture 
consistent with secondary hyperplasia. The serum Oa++ began 
a persistent fall until death. They felt that this represented 
production of a trophic substance by the t~~or which stim-
ulated the parathyroids. However a fourth pa.rathyroid gland 
was found at autopsy and it is generally hopefully asslITlled 
by surgeons performing a total thyroidectomy that a single 
gland is adequate for normal parathyroid function. This 
1,'Uould not appear to be due to high preoperative Ca++ causing 
temporary parathyroid suppression. 
(Q) ,v 
Abouav, Berkowitz, and Kolb, in 1959, (15) reported a case 
of masculin.izing hyperneprlI'oid ovarian tumor associated with 
hypercalcemia and hypophosphatemia. Tubular reabsorption of 
phosphate was 85% and there was a hypophosphaturia. They 
believe that this is the usual finding in cases of this t;ype 
and therefore argue that the humoral substance is not para-
thOr!110ne because it lacks phosphaturic qualities. They 
believe that the hypophosphatemia in their case is due to 
the normal body homeostatic mechanisms ~vhich tend to main-
tain the physiochemical relationship ACa++ • AP04 _ = K. 
In this belief then, they feel that the phosphate reabsorption 
can be used to differenciate between primary hyperparathy-
roidism and parathorruomimetic turaors. The sermu Ca++ fell and 
the phosphate rose following removal of the tunlOr. 
In the CPC of the New }!~ngland Journal of lViedicine, October, 
1963, (16) a case of adenocarcinoma of the transverse colon 
with extensive metastasis to the liver was presented. This 
patient had hypercalcemia, hypercalcuria and hypophosphatemia 
without evidence of metastatic bone disease. The parathyroid 
glands l>lere normal at autopsy. The patient also had a high 
alkaline phosphatase. Dr. Armen Tashjian, by use of a quanti-
tative complement fixation reaction and an antigen reacting 
with the specific antiparathyroid hormone, antigen to Hparathy-
roid hormone n was detected, approximately 6 microgm. of 




per gram of metastatic tumor. No antigen was found in sur-
rounding tissues. He uses an antiserurr! to bovine parathor-
mone which shows serologic cross reactivity with human para-
thormone (unpurified). That this is actually parathormone 
and not tissue components with antigenic cross reactivity 
has not been definitely established. 
Soldberg and Tashjian, et al (8) have a series of 18 
patients, with chemical abnormalities associated ",lith tWllors 
arising outside the parathyroid glands without bony metasta-
sis. Seven are renal cell, 3 are bronchial, 2 ovarian carcinoma 
and 1 each of endometriurn, bladder, vulva, generalized lym-
phoma plus reticulum cell sarcoma and hemangiosarcoma of the 
liver. In 10 of the 18 cases parathyroid examination was 
reported. One was adenomatous, one hyperplastic, and eight 
were normal. In all 10 cases in which the tumor was removed 
the serum calcium returned to normal but subsequently rose in 
3 cases when the tUlIlor recurred. The serum phosphate was 
conSistently low in 11 of the 17 cases and the serma alkaline 
phosphatase was elevated in 7 of 15 cases. 
Finally, for variety, lrJoolner, Keating, and Blank (17) 
presented a case of a woman who had primary hyperparathy-
roidism resulting from a parathyroid adenoma. One year pre-
viously an adenocarcinoma of the breast had been surgically 
removed. Operation disclosed a parathyroid turnor that lllias the 
site of metastasis from the adenocarcinoma of the breast. 
(10) 
III. iYIechanism of Action of Parathormone 
If parathormone is indeed produced by some neoplasms, an 
understanding of its action and effects is necessary to derive 
any clinical benefits from this finding. 
The parathyroid hormone has recently been isolated by 
Rasmussen and Craig (18). It is a polypetide with a mole-
cular weight of approximately 9,500 and is homogeneous by 
counter current distribution, paper and column chromato-
graphy and ultra centrifugation and posses calcium mobilizing 
and phosphaturic activity. It can be partially hydrolysed 
without complete loss of biologic activity and this is probably 
the explanation for some false results obtained with cruder 
extracts. 
Parathormone has been found to have effects at four 
target organs. These include bone, the kidney, the gastro-
intestinal tract and the lactating breast. The main biochemical 
effect of this hormone seems to be associated with the trans-
port of calcium across a variety of membranes (intestinal 
epithelium, renal tubule, bone cells and mammary epithelium), 
and it also seems to be involved in the uptake and turnover of 
phosphate in the kidney and possibly other organs. 
f.eripheral Effects of Parathormone on the Kidne~ 
It seems well established that parathyroid hormone controls 
(11) 
the renal excretion of phosphate (19, 20, 21) but the manner 
in which it does this is a subject of controversy, either by 
increasing the glomerular filtration rate or by its control 
over the tubular reabsorption or excretion. However from the 
work of Jacobs (22) and Hint and Thomas (23, 24) it appears 
that the more significant is the control of' tubular reabsorp-
tion or secretion of phosphate. The bulk of the proof is 
derived from experiments which show a rapid and sustained 
increase in the urinary phosphate excretion with no change 
in the clearance of inulin following adequate doses of 
parathormone. Unilateral perfusions of dog kidneys have 
given similar results and retrograde infusions in the chicken 
which has a I'enal portal system whereby only the tubule is 
perfused have given simileI' results, i.e. increased phosphate 
excretion without an increased GPR. 
That this is primarily a secretory rather than a decreased 
reabsorption response is supported by nicholson (25) 1111ho 
suggests that the hormone controls the rate of phosphate 
excretion at the distal tubule. This is supported by the 
work of deVerdier (26) who has shown an increased turnover 
of' P32 in the renal tissues of animals tre8.ted with para.thy-
roid extract, which is more consistent with an increased 
secretion rather than a reabsorption of phosphate. Thus the 
effect of !larathormone on the kidneys in regard to phosphate 
is primarily an increased secretion of phosphate in the dis-




Parathormone also seem.s to influence the rate of calcium 
reabsorption by the renal tubule. This is supported by data 
from Albright and Ellsworth (2) that shows the initial effect 
of ad..ministration of parathormone to a hypoparathyroid animal 
is a fall in urinary calcium presumably due to an elevation 
of the Tm for calciu~ in the renal tubule. It is only after 
the plasma Ca++ becomes elevated that the hypercalcuria 
develops. Likewise following parathyroidectomy there is an 
increased excretion of calcium and this is followed by 
hypocalcuria only after the plasma Ca++ has fallen signifi-
cantly. This suggests that there is a decreased rate of 
tubular reabsorption in the hypoparathyroid state. Although 
these actions upon the renal handling of Ca++ and P04= are 
the most striking effects which follow the administration of 
parathormone, other effects have been observed which may be 
refined and also used as indicators of excessive parathormone 
activity_ 
.Follov-ling rapid infusion of a purified parathyroid 
extract in hypoparathyroid patients, Rich (27) found a rapid 
onset of increased citrate excretion, an elevation in urinary 
pH and an increase in total solute excretion. Possible these 
can be attributed to an increased tubular phosphate secretion 
resulting in increased Na+ excretion and decreased Ne:+~H+ ex-
change, an elevation of pH with resultant increased citrate 
(13) 
Na+ and H+ excretion. The increased solute excretion is of 
interest in view of the suggested diurectic effect of parathor-
monee 
Perirheral Effects of Parathormone on Bone 
1'he effects of parathormone on bone may be theorized as 
follows: (28) The primary action of the hormone is to convert 
potentially osteogenic cells from osteoblastic into osteolytic 
cells, either multinucleated gia:4nt cells or an osteolytic 
fibroblast which elaborates an rgentophil fibrous tissue. 
I 
This results in increased bone ~esorption possibly by increas-
ing acid production and increaSilng acid phosphatase activity, 
resulting in the destruction of both matrix and bone mineral. 
The release of the latter tends Ito elevate the level of both 
ACa++ and AHP04:';::. This fall of lion product is buffered by 
I _ 
the withdrawal of calcimn and PlosPhate from the exchangeable 
calcima of bone. Since the kidley is more sensi ti ve and 
responds more rapidly to the hOrrOne, the first effect upon 
bone is probably withdrawal of clalcium and phosphate. Bowever, 
as soon as bone resorption is i1creased, and the ACa++ • ABP04= 
:.;:: K is returned to normal, calci'um and phosphate leave the extra-
cellular fluid and return to the exchangeable bone mineral. 
!rhus this compartment serves a bluffering function. Although 
this buffering function superficially appears to be a simple 
physiochemical process, there is much to suggest that the 
exchange is controlled by the cellular activity of the osteo-
blasts. Although the initial effect of the hormone is to 
decrease osteoblastic activity, the increased bone resorption 
leads to a weakening of the bone, which leads to mechanical 
stress and compensatory activation of resting osteogenic cells 
into active osteoblasts, resulting in an increased rate of 
bone growth and mineral accretion. In mild hyperparathyroidism 
this compensatol'Y change may be sufficient to maintain a 
nearly normal amount of total bone tissue. However, with 
more severe deerees of hyperparathyroidism the compensatory 
increase in osteoblastic acti~ity is insufficient, an 
- imbalance between osteogenesis and osteolysis develops, and 
bone density as observed radiologically decreases, leading 
to the classic picture of hyperparathyroidism with I'arefaction 
of hone and fractures. In this process the trabeculae and 
certain areas of cortical bone appear to be more sensitive to 
the action of the hormone and exhlbit the pathologic changes 
sooner and to a greater degree than the major part of cortical 
bone. 
Perinheral Effects of ParathoHQone on the Gastrointestinal --.... ·-----------·'--TraCt-----------'---
Parathormone seems to increase the rate of absorption of 
Ca++ by the ~.I. tract (28). This has been shown by taking 
loops of bowel trom normal fmd parathyroidectomized rats. 
The loops from the hypoparathyroid rats had a decreased 
ability to develop and maintain a concentrated gradient of 
cale-ium between serosal and mucosal fluid. Thus parathyroid 
hormone is necessary along with Vi ta...'11in D for adequate 
calciv~ absorption. 
For the purpose of this paper, the most important effect 
of the hormone is that on the kidney, because the earliest 
effects of hypersecretion v-JOuld be manifest in changes of 
function in the organ most sensitive to its action, that is 
the kidney. The best explanation for this seems to lie in 
the fact that in the dog kidneys, as estimated by Copp (29), 
roughly 20-26% of the resting cardiac output perfuses the 
kidneys in contradistinction to 3-7% total blood flow to the 
bone. Also Neuraan and Neu.man (30), by the use of isotopes 
(deuteriwn), showed that injected deuteriwn equilibrates 
alrllost immediately with soft tissues but is only 909; complete 
in bone at the end of 4 hours. Since parathyroid horrnone is 
a relatively large molecule it would diffuse slowly through 
the bone and depend on local blood flow to get to its site 
of actioX}, the bone cells. This system has an. inherent 
stabili ty tending to smooth out slight cnan:;es in circulating 
hor:rnone and would be slow to respond to larger variations in 
hormone concentrate. rEhe kidney, on the other hand, would have 
all cells reached essentially Simultaneously and would be more 
sensitive to small changes in the concentration of circulatory 
(16) 
hormone. By using phosphate excretion as a test or renal 
response and an increase in serum calciv.1i1 as an indicator 
or osseous response, the difference between the onset of 
action of parathormone can be shown. If adequate doses or 
par'athormone are given the maximal renal response is obtained 
in 15-45 minutes; whereas, the increase in serum calcium 
occurs in six or more hours (31). Also if serum Ca++ is 
decreased by the use of EDTA a change in the urinary excretion 
of phosphorus occurs H'i thin 20 minutes. 
The erfect on the kidney is thus more rapid, but also 
limited in magnitude. During prolonged administration or 
the hormone the serum calcium will continue to increase until 
death occurs. However after a certain doseage level no 
further effect upon urinary phosphate excretion can be 
obtained (28) and despite an increased Tm for calcium, when 
a significant hypercalcemia occurs, hyperca1curia ensues. The 
effect of parathyroid hormone can be summarized thusly: 
Response Bone Kidney G.I. Tract 
Onset Slow Rapid InteFlnediate 
Sensitivity Insensitive Sensitive 
Magnitude Unlimited Limited Limited 
(17) 
From the above then it is possible to conceive the 
regulation of' parathyroid activity by regulation of' ACa++. 
The kidneys are a rapid and sensitive regulator which respond 
to small hormone concentration and in a limited capacity; 
whereas, the bone is slow to respond and insensitive, but 
of' nearly unlimited capacity. Thus, a f'all in the ACa++ of' 
the plasma stimulates the parathyroid glands to secrete 
more hormone. The hormone acts upon at least three peri-
pheral tissues, the kidney, the bone, and the gastrointest-
ina.l tract. Its ef'f'ect upon the kidney is to increase the 
tubular resorption of calciu.m; upon the bone to increase 
resorption; and upon the gastrointestinal tract to increase 
absorption. All these effects tend to elevate directly the 
ACa++ of plasma, which in turn shuts off the further produc-
tion of hormone by the gland. In addition, an increased rate 
of bone resorption leads to an increased release of phosphate 
into the plasma. However, the hormone has an additional 
action upon the kidney, that of increasing distal tubular 
secretion of phosphate. This effect results in a lowering 
of A = which usually more than offsets the rise produced 
HPO~_ 
by the resorption of bone. The net result is a decrease of 
A
EP04
= which leads to an increase of ACa++' due to their 
interrelationship (ACa++.AHP04= =K). 
(18) 
IV. Symptoms of Hypercalcemia 
Since hypercalcemia is often the cause of the presenting 
complaints of these patients, and the symptoms are a rough 
guide to the therapy, it is imperative that one be f~uiliar 
with the effects of hypercalcemia. (32) 
The various manifestations of hypercalcemia rnay be 
categorized by their effect on the nervous system, gastroin-
testinal tract, kidney, heart and metabolic alterations. 
A high calcium level results in a diffuse disturbance in 
the electrical activity of the brain which can be demonstrated 
by an electroencephalogram. The resultant s'Jrn1ptoms are 
lassitude, somnolence and stupor which progress eventually 
to coma and death. There also may be occasional convulsions 
and variable changes in the deep tendon reflexes. 
The gastrointestinal symptoms are prominent and include 
anorexia, nausea, vomiting and constipation although occasion-
ally diarrhea. There may also be duodenal ulcer disease and 
pancreatitis. 
The effect on the kidney is the inability to concentrate 
urine with a resultant polyuria and polydipsia. There also 
seems to be a direct effect on the distal tubule with loss of 
potassi~~, sodiunl, and magnesium and subsequent hypokalemic 
alkalosis. 
The effects on the heart are usually changes in electrical 
acti vi ty of the myocardiUt"11 t'l1"i th a shortened Q,T interval, 
(19) 
.- lowering of the T waves and lowering or sagging of the P waves. 
The effect on skeletal muscle seems to be depressant with 
resultant muscle weakness. 
(20) 
V. Differential Diagnosis of Hypercalcemia 
In order to qualify for the category of a "parathormone 
secreting neoplasm" it is mandatory that all other possible 
causes of hypercalcemia be ruled out. 
The first thing that comes to mind in these days of 
generalized useage of nonprescription vitamins is hyper-
vitaminosis D. Since D is a fat soluble vitamin it cannot 
be excreted by the kidney and thus is cmTlulative. The clue 
here is usually the history. Also in Vitamin D intoxication 
there is usually a hyperphosphatemia which is not character-
istic of the syndrome under consideration. (33) A more 
refined test is a trial of therapy with cortisone which is 
said to be antagonistic to Vi tarnin D and would thus lower 
serura calciuu ... 
About 10% of patients with sarcoidosis have hypercalcemia 
and they may have hypercalcuria with or without hypercalcemia. 
Many investigators (34, 35) (37) feel this is due to an endo-
genous hypervitaminosis D and cortisone treatment will indeed 
reduce the hypercalcemia and can thus be used as a diagnostic 
adjuvant. Calcium balance studies will show increased uptake 
of calcium with decreased fecal calcium. Blood phosphate 
and alkaline phosphatase may be normal or elevated. Other 
aids in the diagnosis of sarcoidois include the Kveim reaction, 
and tubercle biopsy. Findings of pulmonary lesions ,.hilar and 
(21) 
general lyrr~hadenophaty, uveoparotid fever, skin lesions, 
erythema nodosLLl11, rheumatoid-like arthritis and granulomatous 
uveitis should make one suspicious of sarcoidosi.(J3) 
The so-called IvIilk Alkali syndrome may present a problem 
in the differential diagnosis. There is usually a history 
of excessive milk and absorable alkali ing;estion for the 
treatment of peptic ulcer disease. In addition there is 
hypocalcuria and hypophosphaturia" and azotemia as opposed 
to the findings in excessive parathormone secretion. l~[arked 
renal insufficiency with alkalosis, azotemia and nephrocal-
cinosis are also findings. (16) (38) 
Immobilization is another cause o.f hypercalcemia. (40) 
Especially in the .first 3-4 weeks when bone reabsorption is 
at a height and osteoporosis is developing. However, the 
serum phospbate is norT-lal or elevated and tubular phosphate 
reabsorption is normal. Also a trial of therapy (ie) mobil-
ization will cause a drop in serum calcium even to the point 
or hypocalcemia. This cause of hypercalcemia can usually be 
elicited by history, but it is an im.portant point to remember 
in the treatment of people with Pagets disease and hypercal-
cemia of other causes. 
In multiple myeloma, -ltJoodard {l) has a series of 80 
patients in which the average serum Oa++ is 11.1.1-4 mg and 21ft 
had a serum. Oa1-+ graa tar than 12.1111g% and another 157~ had 
serllill Oa++ greater than 13.1 mgt. That this is not due to 
(22) 
.,-. 
increased plasma protein is attested to by the fact that it 
is the globulins that are increased and the albumin is nor-niBl 
or usually decreased. The albunlin fraction is responsible 
for the majority of calcimrl binding. Also in the vJoodard (1) 
series the alkaline phosphatase was greater than 5.1 BU in 
20::b of his patients. The plasma phosphate is usually normal 
or elevated in multiple myeloma. '11his disease can usually 
be ruled out by skeletal roentgenograms and appropriate mar'row 
aspirations, electrophoresis, and detection of Bence Jones 
protein in the urine. 
Osteoporosis and osteomalacia are not usually a problem 
in the differential diagnosis since sermu Ca++ and POl:: are 
L/-
ei ther normal or decreased. (33) 
Paget's Disease can present a problem in the differential 
diagnosis betli>leen it and pri:mary hyperthyroidism ",Ii th Brown 
tml10r formation. However theseru...rn phosphate is normal or 
increased and the phosphate reabsorption test will usually 
make the distinction. (36) 
Since estrogen therapy has been shown to cause hypercal-
cemia, it may be contraindicated in certain cases of breast 
and prostate carcinoma. (1, 39) (45) It has also been postu-
lated that some mechanism is present in the body which can 
convert androgens to estrogens and thus produce a hypercalcemia. 
Cancer metastatic to bone presents a problem in the 
differential diagnosis. It is generally accepted that in about 
9% of all cancers metastatic to bone there is a hypercalcemia 
(23) 
/ 
during the course of the disease. (1) This is apparently 
true in all neoplasms except that of the thyroid. In exten-
sive studies of serum phosphorus the results have ah.rays been 
equivocal. (1, 12, 13) This leads one to believe that these 
series may be mixed, that is they may contain both turnors 
causing hypercalcemia by excessive osteolysis and exceeding 
the renal excretory capacity and also hormone-producing 
tuxaors. There is nothing to prove that these so-called 
hormone-producing turnors cannot metastasize to bone and thus 
cannot be considered as a factor in the muddled results of 
phosphorus metabolism in metastatic bone disease. Therefore 
it seems unlikely that marrow aspiration for tumor cells and 
skeletal roentgenograms can decide whether or not one is 
dealing with a hormone-producing turnor or not. Rather the 
answer would lie in the phosphorus metabolism or some other 
more discrete indicator of excess hormone activity_ 
The differential diagnosis between primary hyperpara-
thyroidism and parathormone secreting tumors will be covered 
in the section titled "discussion". 
Other causes of hypercalcemia such as thyrotOXicosis, 
Gaucher's disease, Nieman Pick disease, Hand Schuller Christian 
Syndrome, Hodgkin's disease, osteogenesis imperfecta, osteo-
myelitis, xanthomatOSis, chronic radium poisoning, polycy-
themia vera, etc. must of course be considered. Idiopathic 
hypercalcuria more recently has often been found to be pri-
mary hyperthyroidism by more s ensi ti ve tests. (L!-l) 
-
VI. Discussion 
At this point there have been enough well docmnented cases 
presented to show the ~xtreme likelihood of the presence of 
certain tumors capable of producing a picture very slluilar 
if not identical to prLllary hyperparaGhyroidisrn. 
Some argue that the hypercalcemia is due to skeletal 
metastasis 'lrJ11io11 are so minute that they are undetectable 
by radiographic and microscopic m.eans. This would seem to 
be refuted by the observance of these patients over a long 
period of time without developm.ent of observable metastasis. 
To maintain high enough serum Oa++ levels to supersede to 
the kidneyst ability to excrete over a. long period of time, 
especially in anOl"ectic hypercalcemic cancer patients without 
some bony change is inconceivable.. The serum Ca++ also seem 
to fall l'>apidly following surgical removal of the twnor. Some 
may argue that this is a phenomenon sirnilar to choriocarcinoma 
of the uterus where the metastases seem to disappear following 
removal of the primary twnor. That is, the satell:Lte cancers 
are dependent on the primary. However, small metastases in 
soft tissue do not see:m to regress following the removal of 
the primary tumor. Also the presence of the hypophasphatemia 
cannot be explained on the basis of unobservable skeletal 
metastases. In aLllost all cases of bone destruction by a 
(25) 
~ .. 
neoplastic process that is widespread enou{!h to cause hyper-
calcemia there is normal or slightly increased serUJil phosphorus. 
}lyers (12), in one report, shows a serU.lli phosphorus which 
rouShly parallels the rise in serum calcium in an exacer-
bation of metastatic bone disease, although the serwn phos-
phorus never reaches abnormal levels. \v11en treatment is 
begun the seru:m phosphorus falls along with serum calcivJr1 
and a concomitant rise in alkaline phosphatase which signals 
the beginning of osteoblastic activity. Thus in pure metas-
tatic bone disease one sees normal or slightly increased 
serum phosphorus levels but not hypophosphatemia. Although 
the serum calcium does rise a phosphate diuresis is not 
observed as an attempt to maintain Aca++ • Ap04= = K. 
One theory that has been advanced is that there is 
increased production of an endogenous Vitrunin D like substance 
such as in sarcoidosis. However, calcium balance studies 
done by stone and Waterhouse (9) showed that their patient 
was in a negative calcium balance of 286 mg per day over a 
6 day measurement period when Ca++ intake was 34l-~ mg per day 
and fecal Ca++ was 307 mg per day. This was in spite of 
200 mg per day cortisone acetate therapy. 
Another explanation that has been advanced is the presence 
of an abnormal substance which binds calcium and transports 
it in excessive arrwunts, thus accounting for the hypercal-
cemia by production of a secondary hyperparathYI'oidism. 
(26) 
Studies, however, by Plilnpton and Gellhorn, (4) on Howe 
fractionation of plasma proteins and eletrophoretic patterns 
have shm..rn no abnormal protein. Also studies to isolate a 
circulating mucopolysaccharide have failed, and no calcium 
binding lipid or cephalin has been found in adequate amounts 
to explain the abnormalities observed. 
Schatten, Ship, et 13.1 (14) observed that the spinal 
fluid calciml1 was lower than 1rlhat would be expected from the 
total serum calcium values and total serum protein. However 
by rapid infusion of human albumin they produced a prompt 
rise in total serwn calcium which suggested that the calcium 
was normally bound. Also evidence of ultracentrifuged studies 
indicated a normal relationship of bound calcium to serum 
protein. Howard and cO-~'J'Orkers (42) have also found that in 
primary hyperparathyroidism spinal fluid calcium 1s lower 
than one would predict. In his case of apparent parathormone 
activity, Connor (3) found that the spinal calcium was lower 
than expected. Thus this is another parallelism between 
primary hyperthyroidism and parathormone secreting tmllors. 
It would seem fairly well substantiated that a humoral 
substance is produced by some neoplasms. The problem now 
is to decide whether it is: (1) A parathyrotrophic substance, 
(2) A substance resembling parathormone but not containing 
phosphaturic qualities, (3) :sreakdown products of tml10r with 
production of substances with phosphaturic attributes, or 
(27) 
(4-) Actually parathormone. 
Stone and Waterhouse (9) believe that some trophic 
substance is produced because they seemingly cured the 
hypercalcemia by removal of 3 out of 4 parathyroid glands 
thus showing that the hypercalcemia was dependent on the 
presence of intact parathyroids. Secondly, the glands 
removed by them were described as resembling secondary 
hyperplasia of the parathyroids. This is, however, the 
only case reviewed in which the parathyroids have been des-
cribed as abnormal. Their patient progressed rapidly to 
death following the operation with hypocalcemia being a 
prominent factor in the decline. A 4th gland was removed 
at autopsy and also found to be hyperplastic. 
Abouav, et al (15) believes that the hypercalcemia is 
due to elaboration of a hurnoral substance by the tumor 
which has an action on bone like parathormone but lacks 
phosphaturic qualities. Their patient had nOYillal phosphorus 
reabsorption studies (85%), but also a hypophosphatemia and 
increased urine 24 hour phosphate excretion. They account 
for the hypophosphatemia on the basis of the body's tendency 
to maintain Aca ++. ApOL~= = K. Thus they claim that the 
hyperphosphaturia is due to an "attempt by the body to main-
tain this. constant,n but in fact, one of the major methods of 
maintainlng this constant is by phosphaturia which is 
mediated through the parathyroid glands. 
(28) 
If there is a substance produced by some neoplasms 
which resembles parathormone in its activity on bone then 
it is logical to assume that there would be an increase 
in both serum calcium and phosphorus in direct proportion 
to their concentration in bone. This would then exceed 
the solubility product of ACa ++ • ApO!..j..:: = K and there would 
be metastatic calcification. This however does not happen, 
but rather there is a decrease in serum phosphate. Assmning 
that the system is receiving an adequate intake of calcium 
and phosphorus and that the glomerular filtration rate 
remains constant, then the only way for the body's homeo-
static mechanisms to lower serum phosphorus would be through 
increased tubular activity. Thus when the body is presented 
with an increased load of calcium and phosphorus it responds 
by increasing phosphorus excretion. Therefore per cent 
tubular reabsorption studies should show a decrease. 
Schaff and Kyle (47) have also shmvn that increasing 
serum calcium in normal subjects has no effect on phosphate 
per cent tubular reabsorption, but the addition of para-
thormone lowers the percentage of phosphate reabsorption. 
Another possible source for the difference claimed by these 
investigators is that their report deals with a masculinizing 
ovarian turQor and studies done by them showed increased 
serum androgens. Experimental work has shown nonspecific 
effects of adrenal hormones on the parathyroid gland. (43, ~-4) 
(29) 
Stewart and Bowen (46) have demonstrated a phosphaturic 
action of spleen and thyrllUS extracts. This can thus raise 
the possibility that the phosphaturic activity of some of 
these tumors is not due to parathormone, but simply tissue 
breakdown products. Sufficient 'lflOrk has not been done in 
this field to reach any definite conclusions. 
Finally, there is the theory that these twuors secrete 
parathormone. If this is the case then the symptoms and 
laboratory findings should be the same as in functioning 
parathyroid adenoma because there lrJOuld be continued 
release of parathormone unrelated to serum ACa++. The 
laboratory findings in hyperparathyroidism are hypercalcemia, 
hypercalicuria, hypophosphatemia, hvperphosphaturia, as well 
as some ancillary findings of hyperuricemia, (16) hypokalemic 
alkalosiS, increased solute excretion, increased serura citrate 
and decreased REG magneshun. The symptoms of primary hyper-
parathyroidism are due mainly to the hypercalcemia. The 
laboratory diagnosis can be most readily made on the basis 
of phosphate reabsorption studies. Schaaf and Kyle (4.7, L}_8) 
showed that in control subjects per cent renal phosphate 
reabsorption demonstrated a rr.ean value of 9l.3± 3.3fb. Three 
instances of primary hyperparathYl?oidism averaged 58}:;. 
Elevation of serum calcium in normal subjects failed to alter 
the normal per cent renal phosphorus reabsorption; hm'll'ever, 
Ei.c1di tion of parathyroid lJol'm.one to the calchun infusate pro-
duced a fall in per centage to levels similar to those seen 
(30) 
in primary hyperparathyroidism. These results were repro-
ducible even in the presence of azotemia. Goldman and 
Bassett (49) indicate that phosphate clearance is well 
preserved until G.F.R. is less than 25 mIlmine Goldsmith 
and Ceccarelli (41) have further refined this test and have 
been able to justify surgical eXploration in primary stone 
formers with hypercalcuria and norrnal serum calcium and 
phosphorus. They have found a high percentage of parathy-
roid adenomas in the so called idiopathic hypercalicurias. 
They demonstrated the presence of a morning increase in 
phosphorus excretion in normal and hyperparathyroid subjects. 
Rapid infusion of calcium causes a reversal of this spon-
taneous phosphateric rhythm in normal subjects but not in 
hyperparathyroid subjects. Surgical correction of this 
disease was follo'\tJed by a normal response to calcium infu-
sion. These results may help to explain controversial 
phosphate reabsorption studies and provide better :means of 
control. 
The close correlation between primary hyperparathy-
roidism and parathormone producing turnors is evident. If 
this is the case then a differential diagnosis between the two 
should be impossible unless luckily a parathyroid adenom.a 
was palpated or picked up on a barima swallow. An especially 
difficult problem would be the presence of' a known malig-
nancy, si,nce the two diseases could both be present. 
N'wuerous questions are still in need of answering before 
(31) 
the presence of a parathormone secreting tu.:mor can actually 
be stated with certainty. One would expect if there were 
excessive secretion of pax'athormone the parathyroid glands 
themselves would be suppressed and exhibit atrophy. This 
however, has never been the case in the cases reviewed 
(3,Q-,5,6,7 ,8,1L.-). This area could definitely use some 
detailed pathologic study by a single investigator. 
Another problem is that one would expect these turnors 
to show some likeness to each other regarding cellular 
patterns and structure. So far no COIilIllOn structure has been 
found. However, Abouav, et 13.1 (5) stated that their tumor 
lvi th apparent para thormone acti vi ty morphologically resembled 
parathyroid carcinoma. Also Schatten, Ship, et 13.1 (14), 
found that neither their primary carcinoma of the vulva 
nOl' the first metastasis was associated t'\1ith hyperc8.1cemia. 
The picture irJas one of a well diff'erentiated squ8.lnous cell 
carcinoma with pearl formation. The second episode of 
metastasis had a hypercalcemia and th:ts tmnor \17aS extremely 
anaplastic. The appal-ent change in function of the tumor 
was thus accompanied by an unmistakable change in its histo-
logical appearance. 
Another interesting observation regarding secretory 
activity of neoplasms has been made in regard to excessive 
production of ACTH and ADH (51,52,53). These two substances 
are also polypeptides and secretory activity seems to be 
(32) 
correlated with the degree of anaplasia. Thus if breakdown 
products of turnors can resemble these tTtlO products closely 
enout;h to function in an endocrine capacity then it is 
logical to assume that parathormone can be also produced 
by a neoplasm. 
To date there have been no reports of osteitis fibrosa 
cystica from the influence of the turriors, but rather the main 
bone change is just demineralization. (3,4,6,8,14). One 
",wuld seemingly expect to see this. (28) However, if one 
bears in mind that these cells are subjected to many influ-
ences other than the changing levels of parathyroid hormone, 
it is possible to imagine that under proper conditions 
osteoclastic activity will be followed by a compensatory 
increase in osteoblastic activity_ Actually in marked 
hyperparathyroidism, in spite of compensatory osteoblastic 
acti ili ty, the osteoclastic activity predominates, resulting 
in the decreased bone density observed radiologically and 
the fractures observed clinically. In other words, the reason 
for the development of bone weakness and fractures is not due 
to any abnormality of the calcification mechanism but due to 
the fact that the predominant cellular activity is osteo-
lysis and such a large percentage of all bone cells are in 
this state that, despite all the compensatory physiologic 
adjustments, osteoblastic activity is insufficient to maintain 
the normal balance bet"'Ieen accretion and resorp"tion. 
(33) 
In less severe cases it seems likely that the initia.lly 
increased osteolysis leads to compensatory increased osteo-
blastic activity vdth a resulting increased rate of bone 
turnover. This being the case it is misleading to classify 
hyperparathyroidism as occuring with or without bone disease. 
Changes in bone metabolism undoubtedly occur in all cases of 
the disease. However, the generally used indices of such 
changes are so gross that only in moderately severe or long-
standing cases of hyperparathyroidism are abnormalities 
recorded. Also in view of the facts (1) that the availability 
of phosphate is an important factor in the rate of deposition 
of bone matrix, and (2) that the calcium: phosphorus ratio in 
the diet will influence the levels of ACa++ and AHp04= in 
the plasma of hyperparathyroid subjects (and therefore 
influences the supply of phosphate available for bone matrix 
formation), it is important to point out the role which diet 
may play in the rate of progression of the signs of bone disease. 
One field in which further developments should elucidate 
the hormone producing tumor controversy, is the development 
of sensitive assay tests for parathyroid hormone. To date 
attempts at using extracts from tumors have been unsuccessful 
in showing any parathyroid activity in eXperimental anilnals 
(3). Tashjian (16), however, has demonstrated the presence 
of !!parathyroid hormonel! in extracts of these tumors by use of 
an antibody to bovine parathor.mone. Also Berson, et al (50) 
have found that parathyroid hormone concentration in plasma is 
(34) 
in the range of' .1 to 1.0 millimicrog,-1l1. per milliliter. 
This assay technique will surely be sensitive enough to 
determine if' these turnors do indeed secrete parathorrnone. 
(35) 
VII. Surmnary and Conclusions 
A series of patients from the literature with malignant 
neoplasms without bone metastasis has been presented in 
which a syndrome resembling primary hyperparathyroidism has 
been found. It is postulated that these tumors secrete 
parathyroid hormone and that the excess hormone is respon-
sible for the hypercalcemia, hypercalicuria, hypophosphatemia 
and hyperphosphasturia found in these patients. The signs 
of excess hormone production are reduced by surgical removal 
or chemotherapeutic treatment of the neoplasms. They also 
tend to recur with recurrence of the neoplasm. There is no 
typical histological pattern on these neoplasms and they 
arise from numerous primary sites. However, there is some 
correlation between changes in the histologic pattern of 
the turnor and amount of hormone production. 
One investigator has found parathyroid hormone in the 
neoplasm and this is the area where further research will 
probably either refute or solidify the subject of this thesis. 
The work being done in this area is valuable for many 
reasons. It may be used as a screening agent for occult 
neoplasms. It can be used as a guide to therapy and also 
in the screening of the effectiveness of various anti-cancer 
drugs. Also it can help to develop efl~ective treatment for 
the hypercalcemia which complicates the therapy of many ter-
minal cancers. 
(36) 
No definite conclusions can be reached, but it is this 
writerts opinion that such neoplasms do exist and that this 
will eventually be confirmed by pathologic histology and 
hormone assay studies. 
(37) 
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